Schuman Olivia, Robertson-Preidler Joelle, Bibler Trevor M
Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, Texas, USA
Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, Texas, USA.
J Med Ethics. 2022 Jan 6. doi: 10.1136/medethics-2021-107836.
This article discusses the triage response to the COVID-19 delta variant surge of 2021. One issue that distinguishes the delta wave from earlier surges is that by the time it became the predominant strain in the USA in July 2021, safe and effective vaccines against COVID-19 had been available for all US adults for several months. We consider whether healthcare professionals and triage committees would have been justified in prioritising patients with COVID-19 who are vaccinated above those who are unvaccinated in first-order or second-order triage. Given that lack of evidence for a correlation between short-term survival and vaccination, we argue that using vaccination status during first-order triage would be inconsistent with accepted triage standards. We then turn to notions of procedural fairness, equity and desert to argue that that there is also a lack of justification for using vaccination status in second-order triage. In planning for future surges, we recommend that medical institutions base their triage decisions on principles meant to save the most lives, minimise inequity and protect the public's trust, which for the time being would not be served by the inclusion of vaccination status.
本文讨论了对2021年新冠病毒德尔塔变异株激增的分诊应对措施。德尔塔浪潮与早期激增情况的一个不同之处在于,到2021年7月它成为美国主要毒株时,针对所有美国成年人的安全有效的新冠疫苗已经可用了几个月。我们思考在一级或二级分诊中,医疗专业人员和分诊委员会将接种新冠疫苗的患者置于未接种疫苗的患者之上是否合理。鉴于缺乏短期生存与接种疫苗之间相关性的证据,我们认为在一级分诊中使用疫苗接种状况不符合公认的分诊标准。然后我们转向程序公平、公平性和应得权益的概念,以论证在二级分诊中使用疫苗接种状况也缺乏正当理由。在为未来激增情况做准备时,我们建议医疗机构基于旨在挽救最多生命、减少不公平并保护公众信任的原则做出分诊决定,目前纳入疫苗接种状况无助于实现这些目标。